2026 NPPES data Oncology Pharmacist NPI 1225782147 PHARMD
Verify on CMS →

MARK JAO, PHARMD

Oncology Pharmacist in SEATTLE, Washington. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
19
Medicare Part D claims · 17 beneficiaries · Oncology Pharmacist avg: 160
Generic prescribing
26%
generic claims · 74% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: MARK JAO, PHARMD is a Oncology Pharmacist ([object Object]) practicing in SEATTLE, Washington with a Medicare Part D prescribing footprint of 19 claims across 17 beneficiaries — 74% brand-name prescribing .

What stands out: MARK JAO, PHARMD filed 19 Medicare Part D claims in 2023 across SEATTLE, Washington. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

MARK JAO, PHARMD at a glance

Quality data not reported

NPI registry status

Active

Issued 02/09/2022

NPI 1225782147

Primary specialty

Oncology Pharmacist

Niche

1,699 US NPIs in this specialty

Medicare Part D claims

19 88% vs specialty avg

2023 prescription claims

Specialty avg: 160

Specialty distribution in Washington

How Oncology Pharmacist compares to other specialties among Washington providers

Washington providers

Oncology Pharmacist share within Washington

1. Oncology Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Oncology Pharmacist share within Washington

Specialty board-certification context

Estimated specialty board-certified rate — Oncology Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Oncology Pharmacist ABMS/AOA estimate

Est. board-certified rate (Oncology Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Oncology Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK JAO, PHARMD is a Oncology Pharmacist provider practicing in SEATTLE, Washington, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: PHARMD. NPI: 1225782147. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK JAO, PHARMD appears in the CMS NPPES registry as a Oncology Pharmacist provider holding PHARMD credentials at 825 EASTLAKE AVE E, SEATTLE, WA, 98109, with a listed phone of (773) 733-3239. NPI 1225782147 was issued on 02/09/2022. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what JAO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 19 prescription claims written by this provider, covering 17 Medicare beneficiaries and totaling roughly $365K in drug spend, split 74% brand-name and 26% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Oncology Pharmacist is a narrow specialty nationwide, with 1,699 enrolled providers across 50 states and an average of 160 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

825 EASTLAKE AVE E
SEATTLE, WA 98109

Provider Details

NPI 1225782147
Specialty Oncology Pharmacist
Credentials PHARMD
Gender Male
NPI Issued 02/09/2022

License & disciplinary context — Washington WMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 — they are NOT specific to MARK JAO, PHARMD. To verify MARK JAO, PHARMD's current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases

WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

MARK JAO, PHARMD — brand share 74.0%
Specialty average (est.)

74% brand-name claims vs 26% generic, on 19 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

19
Total Claims
$365K
Total Drug Cost
17
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
19
Total Day Supply
532
Brand vs Generic
74% brand / 26% generic
Brand Drug Cost
$292K

Patient Demographics

Average Patient Age
75.8 years
Avg HCC Risk Score
3.12
Age Distribution
<65: 0, 65-74: N/A, 75-84: N/A, 85+: N/A

Oncology Pharmacist Overview

How MARK JAO, PHARMD fits within the Oncology Pharmacist landscape nationally.

1,699
Oncology Pharmacist Providers in US
50
States with Oncology Pharmacist
160
Avg Claims per Provider

MARK JAO, PHARMD's 19 claims are below the specialty average of 160.

Nearby Oncology Pharmacist Providers in Washington

Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as JAO.

Compare Oncology Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK JAO, PHARMD's specialty?
MARK JAO, PHARMD specializes in Oncology Pharmacist and practices in SEATTLE, Washington. Credentials: PHARMD.
How much does MARK JAO, PHARMD prescribe under Medicare Part D?
In 2023, MARK JAO, PHARMD wrote 19 Medicare Part D claims totaling $365K in drug costs for 17 beneficiaries.
Where is MARK JAO, PHARMD located?
MARK JAO, PHARMD is located at 825 EASTLAKE AVE E, SEATTLE, WA, 98109. Phone: (773) 733-3239.
What is MARK JAO, PHARMD's NPI number?
MARK JAO, PHARMD's National Provider Identifier (NPI) is 1225782147, issued on 02/09/2022.
Does MARK JAO, PHARMD prescribe more brand-name or generic drugs?
MARK JAO, PHARMD's prescribing is 74% brand-name and 26% generic drugs by claim count, with $292K in brand drug costs.
How many Oncology Pharmacist providers are there in the US?
There are 1,699 Oncology Pharmacist providers across 50 states in the US. The average Oncology Pharmacist provider writes 160 Medicare Part D claims per year.
Does MARK JAO, PHARMD accept Medicare?
MARK JAO, PHARMD appears in CMS Medicare data with 19 Part D claims and 17 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK JAO, PHARMD's credentials?
MARK JAO, PHARMD's NPI is 1225782147 with credentials PHARMD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology